DYRK1A and Dravet syndrome: Our study further emphasizes DYRK1A as a main contributor of neurogenesis impairment in NPCs and neurons derived from Twin-DS-iPSCs and provides novel insights into the therapeutic potential of DYRK1A targeting in patients with DS.